Anemia play Akebia jumps in trading debut

Akebia Therapeutics Inc. (NASDAQ:AKBA) raised $100 million in an IPO through the sale of a bumped-up number of shares at the high end of its proposed price range. The company sold 5.9 million shares at $17, valuing Akebia at $327.6 million. Earlier this month, the company said it planned to sell 4.9 million shares at $14-$17. Morgan Stanley; Credit Suisse; UBS; and Nomura are underwriters. Akebia was up $9.69 (57%) to $26.69 on its first day of trading Thursday. ...